Macrocytosis Interpreter — High MCV: B12, Folate, Drugs or MDS?

Macrocytosis Interpreter — High MCV: B12, Folate, Drugs or MDS?

Enter the MCV with what is known — B12 and folate against the NICE 2024 and BSH lines, reticulocytes, alcohol, liver disease, thyroid, drugs such as methotrexate, hydroxycarbamide, azathioprine and antiretrovirals, and whether other counts are low. It separates megaloblastic from non-megaloblastic causes, handles the indeterminate B12 with active B12 and methylmalonic acid, and says when a film and a marrow are needed for myelodysplasia.

High MCV (macrocytosis)

MCV + B12 + folate + context → cause
NICE NG239 (2024) lines. ng/L is the same number as pg/mL.
BSH 2014 line.
B12 indeterminate — measure active B12 or methylmalonic acidExample

MCV 112 fL, B12 250 ng/L (indeterminate), folate normal, reticulocytes normal, no alcohol, liver or thyroid disease, no drugs, no other cytopenias

Advertisement
Advertisement

B12 and folate lines, and where they come from

TestDeficientIndeterminateDeficiency unlikelySource
Total B12Below 180 ng/L (133 pmol/L)180–350 ng/L (133–258 pmol/L)Above 350 ng/L (258 pmol/L)NICE NG239, 2024
Active B12 (holoTC)Below 25 pmol/L25–70 pmol/LAbove 70 pmol/LNICE NG239, 2024
Methylmalonic acidAbove the laboratory’s interval—Within itNICE NG239 (second line); BSH 2014
Total B12 (older)Below 148 pmol/L (200 ng/L), or a local cut-offNot defined numerically—BSH 2014
Serum folateBelow 7 nmol/L (3 µg/L)——BSH 2014
133 and 258 pmol/L are 180 and 350 ng/L × 0.7378, the factor the vitamin B12 converter uses. BSH 2014 recommended second-line tests for an indeterminate result but did not set a numerical indeterminate band; NICE 2024 did.

Megaloblastic or not — and why a very high MCV no longer settles it

Macrocytosis — an MCV above 100 fL — divides into megaloblastic causes, where DNA synthesis is impaired (B12 and folate deficiency, methotrexate, hydroxycarbamide, thiopurines, some antiretrovirals), and non-megaloblastic ones (alcohol, liver disease, hypothyroidism, reticulocytosis, and myelodysplasia). In the series summarised by Kaferle and Strzoda, alcohol accounted for 15–65%, deficiency for 6–28%, medications for 2–37%, hypothyroidism for 1–12% and marrow dysplasia for 1–6%, depending on the population.

The size of the MCV is often taught as the clue: above about 110 fL, think megaloblastic. That comes from older series — 87% of marked macrocytosis was due to low folate or B12 in a 1978 study. A 2022 study of 1,032 anaemic patients with an MCV of 110 or more found a deficiency in only 10.7%. This page shows both and does not treat a high MCV as a diagnosis.

The B12 result is the commonest sticking point. NICE NG239 (2024) set numerical bands — deficient below 180 ng/L, indeterminate to 350 ng/L — with active B12 and methylmalonic acid as tie-breakers; the 2014 BSH guideline used 148 pmol/L (200 ng/L) and recommended methylmalonic acid for indeterminate results without defining the band. A normal MCV does not exclude deficiency.

Once deficiency, drugs, alcohol, liver and thyroid are excluded, an unexplained macrocytosis — especially with other low counts — needs a film and consideration of myelodysplasia. See the vitamin B12 unit converter, serum folate unit converter, MCV-based anaemia classifier and pancytopenia interpreter.

Frequently asked questions

What does an MCV above 110 mean?

It is marked macrocytosis. It was long taught to point to B12 or folate deficiency, and a 1978 series attributed 87% of cases to them, but a 2022 study of 1,032 anaemic patients with an MCV of 110 or more found low B12 or folate in only 10.7%. Drugs such as hydroxycarbamide and methotrexate, myelodysplasia, reticulocytosis and liver disease also cause it.

What B12 level is indeterminate?

Under NICE NG239 (2024), a total B12 of 180–350 ng/L (133–258 pmol/L), or an active B12 of 25–70 pmol/L. With symptoms or signs of deficiency, NICE suggests methylmalonic acid as the further test. BSH 2014 used 148 pmol/L (200 ng/L) as its cut-off.

Which drugs cause macrocytosis?

Methotrexate and other folate antagonists, hydroxycarbamide, azathioprine and mercaptopurine, antiretrovirals such as zidovudine, some anticonvulsants, trimethoprim and chemotherapy. Metformin and proton pump inhibitors lower B12 absorption.

Does alcohol cause a high MCV?

Yes, and it is the commonest cause in many series. The MCV with chronic alcohol use is generally below 110 fL, so a higher value suggests another cause as well.

When should macrocytosis be investigated for myelodysplasia?

When B12, folate, drugs, alcohol, liver and thyroid do not explain it — especially with low neutrophils or platelets or dysplastic features on the film. A film review and haematology opinion come first; a marrow examination confirms it.

Related calculators

References

  1. National Institute for Health and Care Excellence. Vitamin B12 deficiency in over 16s: diagnosis and management. NICE guideline NG239, March 2024. — total B12 below 180 ng/L (133 pmol/L) deficiency, 180–350 ng/L (133–258 pmol/L) indeterminate, above 350 ng/L (258 pmol/L) unlikely; active B12 (holotranscobalamin) below 25 pmol/L deficiency, 25–70 pmol/L indeterminate, above 70 unlikely; "Consider a further test to measure serum MMA concentrations in people who have symptoms or signs of vitamin B12 deficiency and an indeterminate total or active B12 test result"; macrocytosis a reason to test, not a requirement for diagnosis.
  2. Devalia V, Hamilton MS, Molloy AM; British Committee for Standards in Haematology. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol. 2014;166(4):496–513. — serum cobalamin cut-off 148 pmol/L (200 ng/L) or a local one, with strong clinical suspicion (2B); homocysteine and/or methylmalonic acid as supplementary tests when cobalamin is indeterminate, MMA the more specific (2B); holotranscobalamin suggested for the future (1B); serum folate below 7 nmol/L (3 µg/L) indicates deficiency (1B); red cell folate not routinely needed (1A); neurological deficiency can occur with a normal MCV (1B).
  3. Kaferle J, Strzoda CE. Evaluation of macrocytosis. Am Fam Physician. 2009;79(3):203–208. — macrocytosis defined as MCV above 100 fL; causes by population: alcoholism 15–65%, B12 or folate deficiency 6–28%, medications 2–37%, hypothyroidism 1–12%, marrow dysplasia 1–6%; "the mean corpuscular volume is generally less than 110 fL with chronic alcohol use"; reticulocytes are larger than mature red cells; drug causes including antiretrovirals, folate antagonists, chemotherapy, anticonvulsants and trimethoprim-sulfamethoxazole.
  4. Soffer S, et al. Low frequency of folate and vitamin B12 deficiency in patients with marked macrocytic anemia. J Gen Intern Med. 2022;37:3504–3505. — MCV 110 fL or more with anaemia in 1,032 of 77,165 patients; low B12, folate or both in 110 (10.7%).
  5. Davidson RJL, Hamilton PJ. High mean red cell volume: its incidence and significance in routine haematology. J Clin Pathol. 1978;31(5):493–498. — 87% of marked macrocytosis attributed to low folate or B12 (figure as cited by Soffer 2022; the original was not re-read).

Not medical advice. For healthcare professionals and education. Reference intervals vary by laboratory and assay — always use your own laboratory's. Never base a dose or a treatment decision on this page alone. Full disclaimer at calcengines.com/disclaimer/